Conducting Phase I Clinical Trials During the COVID-19 Pandemic
An experience of the Drug Development Department of the Gustave Roussy
News in COVID-19
Radiotherapy Delays Due To COVID-19 Reported
Restrictive measures to control the spread of COVID-19 have adverse effect on continuation of radiotherapy in patients with cancer
ESMO’s Expert Consensus: Do Not Discontinue or Delay Cancer Treatment That May Impact on Overall Survival
In Annals of Oncology, ESMO’s comprehensive set of recommendations address open questions on how to manage cancer care in the COVID-19 era
COVID-19 Pandemic Cancer Diagnostic Delay Estimated For England
Modelling studies predict the outcome of COVID-19 pandemic-related cancer diagnostic delays in England
Italian Association of Oncology Nurses Maps the Situation of Cancer Patients Who are Self-Isolated at Home
An interim analysis of survey data in the context of the COVID-19 pandemic
Research Refutes ADT Protective Effect Against SARS-CoV-2 Infection
Data from prostate cancer patients in Italy and Finland do not support the hypothesis that androgen deprivation therapy may reduce the risk of SARS-CoV-2 infection
Assessment of Patients’ Perspective on the Consequences of the COVID-19 Pandemic on Cancer Care
Results from the survey among 5302 cancer patients in the Netherlands
Collateral Damage From COVID-19 Cancer Surgery Delay Revealed
A delay in cancer surgery because of the COVID-19 pandemic may have a significant impact on patient survival
COVID-19-Linked Pancytopenia Case Described
An immunocompromised cancer patient with bone marrow positive for SARS-CoV-2 has developed pancytopenia
‘Substantial’ COVID-19 Burden Revealed For NY Cancer Patients
A study of cancer patients attending a New York hospital details the rates of hospitalisation, morbidity and mortality associated with COVID-19
PRE-ONCOVID-19 Study Findings Confirm High Cancer Patient Mortality Rates
Around 10% of cancer patients with suspected or confirmed COVID-19 die within 25 days of being admitted to hospital with symptoms
Spanish COVID-19 Cancer Patient Mortality Risk Factors Characterised
A study of cancer patients with COVID-19 has identified several risk factors for mortality
Pharmacokinetic and Pharmacodynamic Interactions Between Anticancer and Antiviral Drugs
More safety data is needed in terms of treatment of symptomatic COVID-19 patients with anticancer drugs
Severity of COVID-19 in Lung Cancer Patients
Findings from the MSKCC series
Clinical Characteristics and Risk Factors for COVID-19 Severity and Mortality Among Cancer Patients in Wuhan and Hubei
Findings from two Chinese multicentre, retrospective, cohort studies
COVID-19 Mortality in UK Patients with Cancer on Anticancer Treatments Described
Results of the UK Coronavirus Cancer Monitoring Project
TERAVOLT Consortium Assesses Impact Of COVID-19 Infection On Patients With Thoracic Cancers
The TERAVOLT consortium has identified patient- and treatment-related factors associated with an increased risk for death among thoracic cancer patients with COVID-19 infection
CCC19 Reveals COVID-19 Cancer Patient Mortality, Risk Factors
Cancer patients with COVID-19 have specific risk factors that may help contribute to a high rate of mortality
Fewer Cancer Diagnoses During COVID-19 Outbreak in the Netherlands
Multifactorial reasons involving patients, general practitioners and the healthcare system
ADT Might Protect Prostate Cancer Patients Against SARS-CoV-2 Infection
Prostate cancer patients using androgen deprivation therapy might have a lower risk of SARS-CoV-2 infection than other cancer patients
Lower Antibodies Rate in Cancer Patients After Symptomatic COVID-19 Than In Healthcare Workers
Antibodies more often undetectable in patients who received anticancer treatment in the month prior to testing
A Proactive and Multipronged Approach as COVID-19 Response in India
Balancing pandemic control with providing continued cancer care
First Results from the TERAVOLT Registry: mortality among thoracic cancer patients with COVID-19 is unexpectedly high
Mortality rates do not appear to be associated with any specific type of treatment or comorbidity in this patient group
Italian Researchers Report COVID-19 Modified Treatment Approaches in Patients with Hepatocellular Carcinoma
Treatment delay of at least 2 months reported in only one quarter of patients
First Report on the Prognosis of COVID-19 Patients with Cancer in the US
An experience in New York City
Cancer Core Europe Urges To Close Key Knowledge Gaps on COVID-19 in Cancer Patients
Research priorities related to incidence, morbidity and mortality of COVID-19 specific to patients with cancer
Cumulative Risk Factors for COVID-19 Complications in Patients with Lung Cancer
An accurate COVID-19 screening model could allow early detection and potentially reduce the risk of severe complications and mortality
Cancer Patients, Survivors ‘At-Risk Population’ For COVID-19
Patients with cancer and cancer survivors may have a higher risk of COVID-19 than the general population
Case Study Raises Possibility Of Tocilizumab For COVID-19 Treatment In Cancer Patients
A metastatic renal cell carcinoma patient who developed COVID-19 may have benefited from treatment with an IL-6 receptor inhibitor
Protecting Patients with Cancer Against Severe COVID-19 Disease in France
Guidelines commissioned by the French health authorities
COVID-19 Measures Suggested To Protect Cancer Patients
Actions taken at a Chinese cancer hospital may have prevented the spread of SARS-CoV-2 and COVID-19
COVID-19 Infection and Related Challenges in Aviano Cancer Centre in Italy
Situation in the first half of March 2020
Findings from a Retrospective Case Study of COVID-19 Infection in Cancer Patients in Wuhan: An Emphasis on Severe Events
Analysis of risk factors associated with admission to an intensive care unit, the use of mechanical ventilation or death
Wuhan Cancer Patient COVID-19 Cases Described
Open access: Early data on the transmission of SARS-CoV-2 in Wuhan cancer patients have been published